Characteristics and Treatment Experiences of Individuals Using Injectable Semaglutide for Weight Management, a Cross-sectional Time-series Analysis, Multi-country Study.
The purpose of this study is to collect information for scientific research and to better understand the experiences of participants managing their weight. The study aims to collect valid responses through online interviews from participants. This study is a survey-based study without collection of laboratory data. Duration of the study will be about 14 months.
Protocol Amendment History
1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-26.
Status change: Not Yet Recruiting → Enrolling by Invitation2025-11-24